Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in CRO/CMO Services

GenScript ProBio -- a mAb, Cell & Gene Therapy CDMO -- Raises $224 Million
Biocytogen Closes $60 Million Hong Kong IPO for Animal Models and Drug Development
WuXi Biologics and WuXi AppTec to Spend $2.8 Billion to Build Separate Singapore Facilities
ClinChoice, a Global Clinical CRO, Raises $150 Million from China Investors
Shanghai ZhenGe Completes $100 Million Round for Biologic CDMO Services
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital